Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.

@article{Jeger2009DrugelutingSA,
  title={Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivit{\"a}ts Trial.},
  author={Raban V Jeger and Hans Peter Brunner-La Rocca and Patrick R. Hunziker and Dimitrios A Tsakiris and Christoph Kaiser and Matthias Emil Pfisterer},
  journal={Clinical therapeutics},
  year={2009},
  volume={31 12},
  pages={2886-93}
}
BACKGROUND Drug-eluting stents (DESs) are associated with late stent thromboses, but the exact mechanism of action is unknown. OBJECTIVE The goal of this article was to assess the clinical interaction of glycoprotein IIb/IIIa inhibitors (GPIs) with different stent and vessel types in unselected patients undergoing percutaneous coronary intervention (PCI). METHODS This was a predefined retrospective analysis of the randomized controlled Basel Stent Kosten Effektivitats Trial (BASKET), which… CONTINUE READING